Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.

Maria-Theresa Krauth; Sonja Burgstaller; Veronika Buxhofer-Ausch; Günther Gastl; Klaus Geissler; Felix Keil; Peter Krippl; Thomas Melchardt; Andreas Petzer; Holger Rumpold; Thamer Sliwa; Stefan Wöhrer; Albert Wölfler; Heinz Gisslinger

doi:10.1007/s00508-018-1365-5

Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.

Maria-Theresa Krauth, Sonja Burgstaller, Veronika Buxhofer-Ausch, Günther Gastl, Klaus Geissler, Felix Keil, Peter Krippl, Thomas Melchardt (Co-author), Andreas Petzer, Holger Rumpold, Thamer Sliwa, Stefan Wöhrer, Albert Wölfler, Heinz Gisslinger

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

7 Citations (Web of Science)

Original language	English
Pages (from-to)	495-504
Journal	WIENER KLINISCHE WOCHENSCHRIFT
Volume	130
Issue number	17-18
DOIs	https://doi.org/10.1007/s00508-018-1365-5
Publication status	Published - 2018

Keywords

INTERNATIONAL WORKING GROUP
POLYCYTHEMIA-VERA
MYELOPROLIFERATIVE NEOPLASMS
AVAILABLE THERAPY
COMFORT-II
ESSENTIAL THROMBOCYTHEMIA
RISK MYELOFIBROSIS
STANDARD THERAPY
SCORING SYSTEM
PHASE-III

Access to Document

10.1007/s00508-018-1365-5

Cite this

Krauth, M.-T., Burgstaller, S., Buxhofer-Ausch, V., Gastl, G., Geissler, K., Keil, F., Krippl, P., Melchardt, T., Petzer, A., Rumpold, H., Sliwa, T., Wöhrer, S., Wölfler, A., & Gisslinger, H. (2018). Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management. WIENER KLINISCHE WOCHENSCHRIFT, 130(17-18), 495-504. https://doi.org/10.1007/s00508-018-1365-5

@article{ef202e75943147109539e64859a19072,

title = "Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.",

keywords = "INTERNATIONAL WORKING GROUP, POLYCYTHEMIA-VERA, MYELOPROLIFERATIVE NEOPLASMS, AVAILABLE THERAPY, COMFORT-II, ESSENTIAL THROMBOCYTHEMIA, RISK MYELOFIBROSIS, STANDARD THERAPY, SCORING SYSTEM, PHASE-III",

author = "Maria-Theresa Krauth and Sonja Burgstaller and Veronika Buxhofer-Ausch and G{\"u}nther Gastl and Klaus Geissler and Felix Keil and Peter Krippl and Thomas Melchardt and Andreas Petzer and Holger Rumpold and Thamer Sliwa and Stefan W{\"o}hrer and Albert W{\"o}lfler and Heinz Gisslinger",

note = "Melchardt: Third Medical Department, Division Hematology and Medical Oncology, Paracelsus Medical University Salzburg, Salzburg, Austria;",

year = "2018",

doi = "10.1007/s00508-018-1365-5",

language = "English",

volume = "130",

pages = "495--504",

journal = "WIENER KLINISCHE WOCHENSCHRIFT",

issn = "0043-5325",

publisher = "Springer Nature",

number = "17-18",

}

Krauth, M-T, Burgstaller, S, Buxhofer-Ausch, V, Gastl, G, Geissler, K, Keil, F, Krippl, P, Melchardt, T, Petzer, A, Rumpold, H, Sliwa, T, Wöhrer, S, Wölfler, A & Gisslinger, H 2018, 'Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.', WIENER KLINISCHE WOCHENSCHRIFT, vol. 130, no. 17-18, pp. 495-504. https://doi.org/10.1007/s00508-018-1365-5

TY - JOUR

T1 - Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.

AU - Krauth, Maria-Theresa

AU - Burgstaller, Sonja

AU - Buxhofer-Ausch, Veronika

AU - Gastl, Günther

AU - Geissler, Klaus

AU - Keil, Felix

AU - Krippl, Peter

AU - Melchardt, Thomas

AU - Petzer, Andreas

AU - Rumpold, Holger

AU - Sliwa, Thamer

AU - Wöhrer, Stefan

AU - Wölfler, Albert

AU - Gisslinger, Heinz

N1 - Melchardt: Third Medical Department, Division Hematology and Medical Oncology, Paracelsus Medical University Salzburg, Salzburg, Austria;

PY - 2018

Y1 - 2018

KW - INTERNATIONAL WORKING GROUP

KW - POLYCYTHEMIA-VERA

KW - MYELOPROLIFERATIVE NEOPLASMS

KW - AVAILABLE THERAPY

KW - COMFORT-II

KW - ESSENTIAL THROMBOCYTHEMIA

KW - RISK MYELOFIBROSIS

KW - STANDARD THERAPY

KW - SCORING SYSTEM

KW - PHASE-III

U2 - 10.1007/s00508-018-1365-5

DO - 10.1007/s00508-018-1365-5

M3 - Original Article

C2 - 30043249

SN - 0043-5325

VL - 130

SP - 495

EP - 504

JO - WIENER KLINISCHE WOCHENSCHRIFT

JF - WIENER KLINISCHE WOCHENSCHRIFT

IS - 17-18

ER -